Ocular Therapeutix, Inc.

Contributing Author

Recent Articles by Ocular Therapeutix, Inc.

Jun-16	Ocular Therapeutix to Participate in Clinical Trials at the Summit (CTS) 2025 OCUL GlobeNewswire
May-28	Ocular Therapeutix To Close Enrollment This Week for SOL-R, its Second Registrational Trial Evaluating AXPAXLI in Wet Age-Related Macular Degeneration OCUL GlobeNewswire
May-14	Ocular Therapeutix to Participate in Upcoming Investor Conferences OCUL GlobeNewswire
May-05	Ocular Therapeutix Reports First Quarter 2025 Results and Business Highlights OCUL GlobeNewswire